Inhibition of human subgingival plaque protease activity by chlorhexidine.
Subgingival plaque samples from three discrete sites in each of eight patients with adult chronic periodontitis were used to determine the ability of 0.001, 0.01, 0.1 and 1.0 mM chlorhexidine to inhibit bacterial proteolytic activity. This activity was measured by monitoring the increase in relative fluorescence (excitation and emission wavelengths of 495 and 525 nm, respectively) accompanying the degradation of fluorescein isothiocyanate (FITC)-labelled bovine serum albumin or FITC-labelled transferrin. Chlorhexidine at concentrations of as low as 0.01 mM inhibited the proteolytic degradation of both substrates by more than 50%. As the growth of dental plaque bacteria is dependent upon the liberation of nutrients (amino acids, peptides and carbohydrates) from host-derived macromolecules, similar effects in vivo might explain the ability of chlorhexidine to inhibit plaque formation at subminimal inhibitory concentrations.
Radford
J R
JR
Department of Conservative Dentistry, UMDS, London Bridge, U.K.
Homer
K A
KA
Naylor
M N
MN
Beighton
D
D
D001419:Bacteria / Q000201:enzymology* / Q000378:metabolism; D002710:Chlorhexidine / Q000008:administration & dosage / Q000494:pharmacology*; D002908:Chronic Disease; D003773:Dental Plaque / Q000201:enzymology / Q000378:metabolism / Q000382:microbiology*; D010450:Endopeptidases / Q000378:metabolism*; D016650:Fluorescein-5-isothiocyanate; D006801:Humans; D006868:Hydrolysis; D010518:Periodontitis; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D012710:Serum Albumin, Bovine / Q000378:metabolism*; D013997:Time Factors; D014168:Transferrin / Q000378:metabolism*
D011480:Protease Inhibitors; D014168:Transferrin; D012710:Serum Albumin, Bovine; D010450:Endopeptidases; D016650:Fluorescein-5-isothiocyanate; D002710:Chlorhexidine